Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
Open Access
- 23 August 2023
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-9
Abstract
Among the unknowns in decoding the pathogenesis of SARS-CoV-2 persistent symptoms in Long Covid is whether there is a contributory role of abnormal immunity during acute infection. It has been proposed that Long Covid is a consequence of either an excessive or inadequate initial immune response. Here, we analyze SARS-CoV-2 humoral and cellular immunity in 86 healthcare workers with laboratory confirmed mild or asymptomatic SARS-CoV-2 infection during the first wave. Symptom questionnaires allow stratification into those with persistent symptoms and those without for comparison. During the period up to 18-weeks post-infection, we observe no difference in antibody responses to spike RBD or nucleoprotein, virus neutralization, or T cell responses. Also, there is no difference in the profile of antibody waning. Analysis at 1-year, after two vaccine doses, comparing those with persistent symptoms to those without, again shows similar SARS-CoV-2 immunity. Thus, quantitative differences in these measured parameters of SARS-CoV-2 adaptive immunity following mild or asymptomatic acute infection are unlikely to have contributed to Long Covid causality. ClinicalTrials.gov (NCT04318314).Keywords
All Related Versions
Funding Information
- RCUK | Medical Research Council (MR/W020610/1, MR/W020610/1, MR/W020610/1, MR/W020610/1, MR/W020610/1)
This publication has 25 references indexed in Scilit:
- Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responsesJCI Insight, 2021
- Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsCell Reports, 2021
- Characterizing long COVID in an international cohort: 7 months of symptoms and their impacteClinicalMedicine, 2021
- Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal StudyJournal of Clinical Immunology, 2021
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine doseScience, 2021
- Long COVID in a prospective cohort of home-isolated patientsNature Medicine, 2021
- Decoding the unknowns in long covidBMJ, 2021
- How and why patients made Long CovidSocial Science & Medicine, 2021
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionScience Immunology, 2020
- Molecular Diagnosis of Epstein-Barr Virus-Related DiseasesThe Journal of Molecular Diagnostics, 2001